Patents by Inventor Timothy David O'Brien

Timothy David O'Brien has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11936060
    Abstract: A power supplying device that can be used during emergencies is disclosed. The device comprises multiple adjustable battery compartments that can be connected, via switches, to deliver power to an external device connected to at least one power delivery port of the power supplying device. Each adjustable battery compartment includes a fixed lead and a sliding lead so that the multiple different battery sizes can be inserted into the compartment and connected to the device. An external battery connection device or harness can also be used with the power supplying device. The external battery connection device can be used to connect various different kinds of batteries with the power supplying device, such as cordless power tool batteries, cordless appliance batteries, and batteries for radio controlled (RC) devices.
    Type: Grant
    Filed: June 27, 2022
    Date of Patent: March 19, 2024
    Assignee: United Services Automobile Association (USAA)
    Inventors: Eric David Schroeder, Donnette L. Moncrief Brown, Snehal Desai, Manfred Amann, Timothy Frank Davison, Rachel Michelle Ballew, Kelsey Anne O'Brien, Sayeef Rahim
  • Publication number: 20170081726
    Abstract: This disclosure describes, in one aspect, a method that, in general, includes analyzing a tumor tissue sample from a subject for expression of at least two biomarkers, wherein a predetermined ratio of expression of the at least two biomarkers identifies the tumor tissue sample as coming from a subject having a particular subtype of lymphoma; and identifying the subject as having a particular subtype of lymphoma.
    Type: Application
    Filed: September 19, 2016
    Publication date: March 23, 2017
    Inventors: Jaime Freddy Modiano, Aric Mathew Frantz, Timothy David O'Brien, Aaron Lyman Sarver
  • Patent number: 9469879
    Abstract: A method for differentiating forms of lymphoma involves analyzing a tumor tissue sample from a subject for expression of CD28, ABCA5, CCDC3, and SMOC2. The CD28:ABCA5 expression ratio differentiates T-cell tumors from B-cell tumors. The CCDC3:SMOC2 expression ratio differentiates different T-cell tumors. The method can further include administering to the subject from whom the sample was obtained an appropriate treatment for the form lymphoma identified by performing the method.
    Type: Grant
    Filed: March 12, 2013
    Date of Patent: October 18, 2016
    Assignee: REGENTS OF THE UNIVERSITY OF MINNESOTA
    Inventors: Jaime Freddy Modiano, Aric Mathew Frantz, Timothy David O'Brien, Aaron Lyman Sarver
  • Publication number: 20150191790
    Abstract: This disclosure describes, in one aspect, a method that, in general, includes analyzing a tumor tissue sample from a subject for expression of at least two biomarkers, wherein a predetermined ratio of expression of the at least two biomarkers identifies the tumor tissue sample as coming from a subject having a particular subtype of lymphoma; and identifying the subject as having a particular subtype of lymphoma.
    Type: Application
    Filed: March 12, 2013
    Publication date: July 9, 2015
    Inventors: Jaime Freddy Modiano, Aric Mathew Frantz, Timothy David O'Brien, Aaron Lyman Sarver